(RTTNews) - Optinose, Inc. (OPTN), a pharmaceutical company, Thursday announced reverse stock split of 1-for-15, effective from 5:00 p.m. ET, on December 30.
The reverse stock split is intended to regain compliance with the $1.00 minimum closing bid price required for continued listing on Nasdaq.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.